Pseudomembranosa colitis: apropos of a case

Authors

  • Kiopper Tartabull-Poutriel
  • Yudenia Toledo-Cabarcos
  • Elizabeth Nicolau-Pestana

Keywords:

colitis pseudomembranosa, Clostridium difficile, antimicrobianos

Abstract

Background: pseudomembranous colitis is a disease caused by Clostridium difficile in recent times has attracted the attention of the medical community, due to an increase in the incidence in health institutions, as well as in the community, motivated by the more frequent use and sometimes not ordered antimicrobials.
Objective: to describe a case of a patient with a postmortem diagnosis of pseudomembranous colitis.
Clinical case: a 71-year-old male patient with a history of chronic obstructive pulmonary disease and mitral prosthetic valve to receive from several months prophylactic antimicrobial cycles every month to avoid respiratory infections, who is admitted due to scarce diarrheic stools, but frequent with abundant blood and mucus accompanied by fever and abdominal pain, with an intra-hospital torpid evolution until his death, performing the diagnosis of pseudomembranous colitis in the necropsy study.
Conclusions: the pseudomembranous colitis produced by Clostridium difficile is a disease that has to be kept in mind in the diagnoses of hospitalized patients who are under antimicrobial treatment or who come from the community where they were prescribed with this type of drugs.

DeCS: ENTEROCOLITIS, PSEUDOMEMBRANOUS/diagnosis; CLOSTRIDIUM DIFFICILE/drug effects; ANTI-INFECTIVE AGENTS/therapeutic use; AUTOPSY; CASE REPORTS.

Downloads

Download data is not yet available.

Author Biography

Kiopper Tartabull-Poutriel

Especialista segundo grado medicina interna msc en urgencias medicas profesor asistente aspirante a investigador

References

1. Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile

Infection. Nat Rev Dis Primers. 2016;2:16020.

2. Lital Meyer S, Ricardo Espinoza A, Rodrigo Quera P. Infección por Clostridium difficile: epidemiología, diagnóstico y estrategias terapéuticas. Rev Med Clin Condes. 2014;25(3):473-84.

3. Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiologyof community associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med [Internet]. 2013 [citado 05 Mar 2019];173(14):[aprox. 9 p.]. Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2013.7056

4. Penichea AG, Savidgeb TC, Dann SM. Recent insights into Clostridium difficile pathogenesis. Curr Opin Infect Dis. 2013;26(5):447-453.

5. Leffler D, Lamont JT. Clostridium difficile Infection. N Engl J Med. 2015;372:1539-1548.

6. Dupont HL. Diagnosis and management of Clostridium difficile infection. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1216-23.

7. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH et al. Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol [Internet]. 2013 [citado 05 Mar 2019];108(4):[aprox. 20 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23439232

8. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect [Internet]. 2014 [citado 05 Mar 2019];20(Suppl 2):[aprox. 26 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/24118601

9. Martínez Rodríguez AA, Estrada Hernández LO, Tomé Sandoval P, Salazar Salinas J. Diarrhea due to Clostridium difficile inhospitalized patients. Med Int Méx. 2018;34(1):9-18.

10. Longo D. Clostridium difficile infection. Review article. N Engl J Med 2015;372(16):1539-48.

11. Furuya Kanamori L, Stone JC, Clark J. Comorbidities, exposure to medications, and the risk of communityacquired Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015 Feb;36(2):132-41.

12. Kyne K, Warny M, Qamar A. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody againsttoxin A. N Engl J Med. 2000;342(6):390-02.

Downloads

Published

2019-03-30

How to Cite

1.
Tartabull-Poutriel K, Toledo-Cabarcos Y, Nicolau-Pestana E. Pseudomembranosa colitis: apropos of a case. Arch méd Camagüey [Internet]. 2019 Mar. 30 [cited 2025 Jul. 19];23(2):264-9. Available from: https://revistaamc.sld.cu/index.php/amc/article/view/6268

Issue

Vol. 23 No. 2 (2019)

Section

Case Reports

License

Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.

Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.

(Download Statement of potential conflicts of interest)

The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).

This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/